These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 28024700)

  • 1. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.
    Thomas DC; Arnold BN; Rosen JE; Salazar MC; Blasberg JD; Detterbeck FC; Boffa DJ; Kim AW
    Lung Cancer; 2017 Jan; 103():75-81. PubMed ID: 28024700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
    Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
    Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
    Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
    Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of surgical resection in treating small cell lung cancer].
    Ye B; Zhao SH; Liu XY
    Ai Zheng; 2007 Jul; 26(7):795-7. PubMed ID: 17626763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer.
    Rucker AJ; Raman V; Jawitz OK; Voigt SL; Tong BC; D'Amico TA; Harpole DH
    Ann Thorac Surg; 2020 Dec; 110(6):1854-1860. PubMed ID: 32544452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Adjuvant Chemotherapy in Early-Stage Combined Small Cell Lung Cancer.
    Mansur A; Potter AL; Nees AT; Sands JM; Meador CB; Fong ZV; Auchincloss HG; Yang CJ
    Ann Thorac Surg; 2023 Dec; 116(6):1142-1148. PubMed ID: 37245788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should aggressive surgery ever be part of the management of small cell lung cancer?
    Waddell TK; Shepherd FA
    Thorac Surg Clin; 2004 May; 14(2):271-81. PubMed ID: 15382303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.
    Yang CJ; Chan DY; Speicher PJ; Gulack BC; Tong BC; Hartwig MG; Kelsey CR; D'Amico TA; Berry MF; Harpole DH
    Ann Thorac Surg; 2017 Jun; 103(6):1767-1772. PubMed ID: 28385378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for limited-stage small-cell lung cancer.
    Barnes H; See K; Barnett S; Manser R
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011917. PubMed ID: 28429473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
    Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
    Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
    Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate.
    Lim E; Belcher E; Yap YK; Nicholson AG; Goldstraw P
    J Thorac Oncol; 2008 Nov; 3(11):1267-71. PubMed ID: 18978561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.